Video Experimental Relacionado
Updated: Feb 22, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
836
Super-Enhancer-Driven SOX4/SMAD3 Remodelación de la membrana media mediante la regulación del metabolismo de los
Enzhe Lou1,2, Peilong Lai3, Guanjie Peng4
1Sino-French Hoffmann Institute, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 21, 2026
Resumen
Una nueva investigación identifica a SOX4 y SMAD3 como factores clave en la fase de explosión de la Leucemia Mieloide Crónica (LMC) avanzada. Dirigirse a estos factores con Bemcentinib es prometedor para el tratamiento de esta leucemia agresiva.
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- La epigenética es la epigenética.
Sus antecedentes:
- La fase blasta (BP) de la leucemia mieloide crónica (LMC) presenta desafíos terapéuticos significativos debido a la resistencia al tratamiento y a la escasa supervivencia.
- Las alteraciones epigenéticas y la activación aberrante del factor de transcripción están implicadas en la progresión del cáncer, pero su papel en la transición CML-BP no se comprende completamente.
Objetivo del estudio:
- Investigar los mecanismos transcripcionales específicos que impulsan la progresión de la LMC de la fase crónica (PC) a la fase blasta (BP).
- Identificar los factores reguladores clave y los objetivos terapéuticos potenciales para la LMC-BP.
Principales métodos:
- Identificación de los factores de transcripción impulsados por superpotenciadores en la LMC-BP.
- Análisis funcionales para evaluar el papel de los factores identificados en la progresión de la leucemia.
- Análisis de las vías de señalización aguas abajo y las interacciones moleculares.
- Pruebas in vitro e in vivo de terapias dirigidas.
Principales resultados:
- SOX4 y SMAD3 impulsados por súper potenciadores fueron identificados como reguladores clave en CML-BP.
- Un bucle de retroalimentación positiva entre SOX4 y SMAD3 promueve la progresión de la leucemia.
- El eje SOX4/SMAD3 mejora la transcripción y señalización de la tirosina quinasa del receptor AXL.
- La regulación ascendente de LPCAT1 por SOX4/SMAD3 facilita la localización de AXL.
- El inhibidor de la AXL Bemcentinib demostró eficacia en la supresión de la progresión de la LMC-BP.
Conclusiones:
- SOX4 y SMAD3 son reguladores críticos en la LMC-BP, impulsados por superpotenciadores.
- El eje de señalización SOX4/SMAD3-AXL es un mecanismo clave en la progresión de la LMC-BP.
- El bemcentinib representa una estrategia terapéutica prometedora para la LMC-BP.
Videos de Conceptos Relacionados
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
01:16TGF - β Signaling Pathway
10.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
01:33Pleiotropy
43.5K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.5K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K